Month: January 2022

MINNEAPOLIS, Jan. 26, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced the initiation of the company’s global Phase 2 clinical trial of SBP-101 in combination with Gemcitabine and Nab-Paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma, which is referred to as the ASPIRE trial. Arvind Chaudhry MD, PhD, Principal Investigator at Summit Cancer Centers in Spokane, Washington was the first clinical site activated, with approximately 60 additional sites expected to be activated in 2022. Panbela has commenced screening for eligible patients, with enrollment expected to complete in approximately 12 months. The ASPIRE trial is designed as a randomized double-blind...

New Facility Will Be Company’s Largest Fiberglass Plant and Serve the Eastern Canadian Market, Northeast and Upper Midwest of the United States LATHAM, N.Y., Jan. 26, 2022 (GLOBE NEWSWIRE) — Latham Group, Inc. (“Latham” or “the Company”) (Nasdaq: SWIM), the largest designer, manufacturer and marketer of in-ground residential swimming pools in North America, Australia and New Zealand, today announced the company is expanding its facilities to Loyalist Township in Ontario, Canada, in west of Kingston with a 148-acre fiberglass manufacturing plant. With the new facility, Latham will be able to serve markets in both the eastern half of Canada, as well as the northeast and upper Midwest of the United States, producing pools for the company’s fiberglass brands including Latham and Narellan Pools. “We are excited to begin the construction...

Toronto, Ontario, Jan. 26, 2022 (GLOBE NEWSWIRE) — Two Hands Corporation, (OTC Pink: TWOH) is pleased to announce that on January 25, 2022 we filed an Amended and Restated Prospectus with the Ontario Securities Commission. Nadav Elituv CEO stated: “The company has been working hard at growing the business in conjunction with becoming a listed security on the CSE.  As we continue to answer the comments from the regulators, the business has now surpassed $1 million dollars Canadian in sale for 2021. “Our growing student grocery programs for two major universities in the Toronto area have provided a strong increase in fourth quarter sales.  We will continue expanding this unique program in 2022 as well as grow our business to business market share.” “The proposed CSE listing and the filing of the Amended and Restated Preliminary prospectus...

Initial agreement with MITSC to introduce clients to BelfricsBT Blockchain technology products and services in the state of Maharastra, India AVENTURA, Fla., Jan. 26, 2022 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) announced today the launch of its Channel Partner Program to develop relationships and nurture strategic partners throughout India. Belfrics signed an agreement with Maharastra Information Technology Support Centre (MITSC) to market BelfricsBT technology products to businesses based on BelfricsBT blockchain technology portfolio in the state of Maharastra, India. Target customers are primarily governments and large institutions that require scalable enterprise business solutions. MITSC will facilitate BelfricsBT’s product brand development and sales proceeds in the Maharastra market for clients...

NEW YORK, Jan. 26, 2022 (GLOBE NEWSWIRE) — DarkPulse, Inc. (OTCMKT:DPLS) announced that it has filed a Petition against Twitter in the New York State Supreme Court, Nassau County, New York, to compel Twitter to disclose the identities of certain individuals or entities that post regularly on Twitter in an effort to battle the smear campaign that the Company believes is intended to harm its shareholders and investors, drive the price of the Company’s stock down and unlawfully profit on this conduct. The Petition filed today by our attorneys is seeking the identities of certain posters to bring formal lawsuits to stop such defamatory and misleading statements, and to determine whether the posters are profiting on a plan designed to bring down the Company’s stock price by spreading false and defamatory statements about its CEO and...

TORONTO, Jan. 26, 2022 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. (the “Company”) announces it has renewed its at-the-market equity program (“ATM Program”) that allows the Company to issue shares of the Company to the public from time to time at the Company’s discretion, effective until August 6, 2022, unless terminated prior to such date by the Company. This ATM Program replaces the prior program renewed in July 2021 that has terminated. Any Class A Shares or Preferred Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”) or any other marketplace in Canada on which the Class A Shares and Preferred Shares are listed, quoted or otherwise traded at the prevailing market price at the time of sale. Sales of Class A Shares and Preferred Shares through the ATM Program will be made pursuant to the...

Trex We See It Too – TricycleTrex has unveiled a new marketing campaign for 2022 that positions the brand as a visionary partner and trusted foundation for life’s most memorable moments.Trex We See It Too – WeddingTrex has unveiled a new marketing campaign for 2022 that positions the brand as a visionary partner and trusted foundation for life’s most memorable moments.WINCHESTER, Va., Jan. 26, 2022 (GLOBE NEWSWIRE) — Trex Company (NYSE: TREX) is kicking off the new year with a new look, new approach and new message for consumers and the industry. The world’s largest manufacturer of wood-alternative decking and railing, and leader in high-performance, low-maintenance outdoor living products, has unveiled a new marketing campaign for 2022 that positions the brand as a visionary partner and trusted...

– IBIO-202 Designed to Address Unmet Needs for Durability, Access, and Variant-inclusion – BRYAN, Texas, Jan. 26, 2022 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming Manufacturing System®, today shared an update on its lead COVID-19 vaccine program, IBIO-202. iBio recently received the U.S. Food and Drug Administration’s (“FDA”) response to its pre-investigational new drug (“IND”) package for IBIO-202. In light of the feedback received, the Company is moving forward with IND-enabling challenge studies for its second-generation vaccine candidate targeting the nucleocapsid (“N”) protein and plans to file an IND application before the end of calendar 2022. Commercially available first-generation vaccines...

LITTLE ROCK, Ark., Jan. 26, 2022 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by artificial intelligence (AI) that serves brands and agencies, today announced that Richard Howe, Chief Executive Officer, and Wallace Ruiz, Chief Financial Officer, will present at the following investor conferences in February 2022. Alliance Global Partners Emerging Growth Technology ConferenceWednesday, February 2ndOne-on-one Virtual Meetings with Investors Aegis Virtual ConferenceFebruary 25th at 4:00 p.m. ETRegistration: Aegis Virtual Conference Calendar For more information about each conference, or to schedule a one-on-one meeting with management, please contact your respective representative directly, or send an email to Investor Relations at Valter@KCSA.com. About InuvoInuvo®, Inc....

RUTHERFORD, N.J., Jan. 26, 2022 (GLOBE NEWSWIRE) — Blue Foundry Bancorp (NASDAQ:BLFY) (the “Company”), the holding company for Blue Foundry Bank (the “Bank”), today reported a net loss of $19.6 million, or $(0.75) per basic and diluted common share, for the three months ended December 31, 2021 compared to a net loss of $1.8 million for the three months ended December 31, 2020. For the year ended December 31, 2021, the Company’s net loss increased $4.8 million to $36.3 million, or $(2.99) per basic and diluted common share, from a net loss of $31.5 million for the year ended December 31, 2020. The increase in net loss for the period was primarily as a result of the establishment of a $16.7 million valuation allowance on the Company’s deferred tax assets. Earnings per share for the year ended December 31, 2021 was calculated using...